Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 14 Jan 2021 |
10 | Documents in support of Show cause Hearing (SCH) | 23 May 2023 |
11 | Reply to Exam Report (MIS-R) | 24 May 2023 |
12 | Journal Copy | 10 Nov 2023 |
13 | Certificate | 19 Dec 2023 |
2 | Reply to Exam Report (MIS-R) | 29 Jan 2021 |
3 | Reply to Exam Report (MIS-R) | 04 Feb 2021 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 06 Jul 2021 |
5 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 17 Jan 2022 |
6 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 04 Aug 2022 |
7 | TM-M(EXTENSION OF TIME) | 25 Oct 2022 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 03 May 2023 |
9 | Documents in support of Show cause Hearing (SCH) | 23 May 2023 |
1 | EXAMINATION REPORT | 11027194 | 28 Jan 2021 | |
2 | Hearing Notice (Show Cause) | 14042200 | 06 Sep 2022 | |
3 | Hearing Notice (Show Cause) | 15314484 | 29 May 2023 | |
4 | Tribunal Accepted Notice for : 4819952 | 15548057 | 6037171 | 05 Jul 2023 |
The application for Isifrane was made on 14 January 2021.
The trademark applicant for Isifrane is Abbott Healthcare Private Limited.
Isifrane is applied in class(es) 5.
Application for Isifrane is on Registered stage.
Application Id allotted to Isifrane is 4819952.
Trademark agent or attorney for the application is Zeusip Advocates Llp.
Isifrane filed with the Intellectual property office as a WORD.